Not so sure about that. Their costs should be a fraction of what they were with no ongoing trials. I understood their strategy was that the cash raised recently would see them through, until they could secure a cornerstone investment, partnership or sale of the company. Their asset and IP portf0lio does look significantly undervalued with a market cap of $6m and cash on hand of ~ $2m.
IVX Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)